Pityriasis Versicolor. Pityriasis versicolor
Conditions
Interventions
Intervention 1: Intervention group: Group A will receive Cap Itraconazole 200mg twice a day in a month for 4 consecutive month. Ferozsons laboratory (cap icon 100mg). Intervention 2: Control group: Gr
Sponsors
Combined Military Hospital Quetta
Eligibility
Sex/Gender
All
Age
13 Years to 50 Years
Inclusion criteria
Inclusion criteria: Confirmed diagnosis of pityriasis versicolor based on clinical examination supported by Wood's lamp examination Not taken antifungal medication in previous 1 month Ability to adhere to treatment and follow-up visits
Exclusion criteria
Exclusion criteria: Known hypersensitivity to itraconazole or other triazole antifungals Liver disease or abnormal liver function tests Pregnancy or nursing mother Concurrent use of medications known to interact with itraconazole Active antifungal infections other than pityriasis versicolor Immunodeficiency or immunosuppressive therapy Any other medical condition deemed a safety risk by the investigator
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Any side effects during itraconazole treament. Timepoint: 1 week, 1,2,3,4 and 6 months after treatment. Method of measurement: interviewing with the patients and clinical examination. | — |
Primary
| Measure | Time frame |
|---|---|
| Skin lesions consistent with pityriasis versicolor. Timepoint: before start of study then 1 week, 1,2,3,4 and 6 months after treatment. Method of measurement: clinical examination and woods lamp examination. | — |
Countries
Pakistan
Contacts
Public ContactZara Babar
Combined Military Hospital Quetta
Outcome results
None listed